These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16381425)

  • 1. Pertussis update: focus on adolescents.
    Bartell JC; Hayney MS
    J Am Pharm Assoc (2003); 2005; 45(6):762-4. PubMed ID: 16381425
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis: challenges today and for the future.
    Cherry JD
    PLoS Pathog; 2013; 9(7):e1003418. PubMed ID: 23935481
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Have you had your Tdap?
    Merchant VA
    J Mich Dent Assoc; 2012 Sep; 94(9):14-5. PubMed ID: 23029803
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pertussis: current epidemiology and recommendations of the Health Council with regard to vaccination policy].
    van Wijngaarden JK; Huisman J; van der Meer JW; Visser HK
    Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2297-301. PubMed ID: 11143295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for use of Tdap booster vaccines for adolescent immunization: overview of efficacy, safety, and clinical use.
    Hitchcock WP
    Clin Pediatr (Phila); 2006 Nov; 45(9):785-94. PubMed ID: 17041165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.
    Koepke R; Eickhoff JC; Ayele RA; Petit AB; Schauer SL; Hopfensperger DJ; Conway JH; Davis JP
    J Infect Dis; 2014 Sep; 210(6):942-53. PubMed ID: 24903664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults].
    Zawadka M; Lutyńska A
    Przegl Epidemiol; 2012; 66(1):99-105. PubMed ID: 22708307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
    Wilson TR
    J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to pertussis.
    Cherry JD
    Clin Infect Dis; 2007 May; 44(10):1278-9. PubMed ID: 17443463
    [No Abstract]   [Full Text] [Related]  

  • 13. Talk to Patients About: Whooping Cough.
    Price S
    Tex Med; 2018 Nov; 114(11):47. PubMed ID: 30485387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More than just a cough: pertussis, and the nurse's role in school and community health.
    Roper JD
    School Nurse News; 2006 Mar; 23(2):26-8. PubMed ID: 16634406
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents.
    Greenberg DP
    Pediatr Infect Dis J; 2005 Aug; 24(8):721-8. PubMed ID: 16094229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
    Gidengil CA; Sandora TJ; Lee GM
    Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis in developed countries.
    Robbins JB; Schneerson R; Trollfors B
    Lancet; 2002 Aug; 360(9334):657-8. PubMed ID: 12241870
    [No Abstract]   [Full Text] [Related]  

  • 19. Using acellular pertussis vaccines for childhood immunization. Potential benefits far outweigh potential risks.
    Conrad DA; Jenson HB
    Postgrad Med; 1999 Jun; 105(7):165-8, 171-3, 177-8. PubMed ID: 10376057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis: acellular, whole-cell, new vaccines, what to choose?
    Locht C
    Expert Rev Vaccines; 2016 Jun; 15(6):671-3. PubMed ID: 26938372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.